QDEL
QuidelOrtho·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Ample Liquidity
Significant Net Income Decline
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About QDEL
Quidelortho Corporation
A global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine
Healthcare Equipment and Supplies
12/17/2021
08/07/1981
NASDAQ Stock Exchange
6,600
12-31
Common stock
9975 Summers Ridge Road, San Diego, California 92121
--
QuidelOrtho Corporation was incorporated in Delaware on December 17, 2021. The company occupies a leading position in the research and development of rapid diagnostic test solutions, production and drinking water marketing. These diagnostic test solutions mainly include the application of infectious diseases, women's health and gastrointestinal diseases. The company sells its products directly to end customers and distributors, no matter who it sells to, this product is for professional use, mainly in physician offices, hospitals, clinical laboratories, reference laboratories, major universities, retail clinics and health testing centers. The Company markets its products in the United States through national and regional distributors and direct sales outlets. Internationally, the company operates through the arrangement of distributors, mainly selling its products in Japan and Europe, and marketing its products.
Earnings Call
Q1/2025
Estimate EPS0.59
Actual EPS0.74
Estimate Revenue691.90M
Actual Revenue693.00M
QuidelOrtho's Q1 2025: Navigating Tariff Challenges and Growth Contradictions in China Market
May 08,2025 07:31
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.01
Actual EPS0.12
Estimate Revenue611.88M
Actual Revenue614.00M
QuidelOrtho's 2025 Q2 Earnings Call: Key Contradictions in COVID Revenue, Tariffs, and China Growth
Aug 06,2025 01:16
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
QDEL has released its 2025 Q3 earnings. EPS was reported at 0.8, versus the expected 0.47, beating expectations. The chart below visualizes how QDEL has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
QDEL has released its 2025 Q3 earnings report, with revenue of 699.90M, reflecting a YoY change of -3.74%, and net profit of -733.00M, showing a YoY change of -3583.42%. The Sankey diagram below clearly presents QDEL's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
